Monitoring Adherence Using Mobile Technology

University of Colorado, Denver25 enrolled

Overview

This study plans to learn more about how children use their asthma medicines. The investigators would like to see if special electronic monitoring devices that connect to smartphones and computers can help children to better manage their asthma

Study Type

OBSERVATIONAL

Enrollment

Conditions

Asthma

Interventions

Propeller Health Monitoring DeviceDEVICE

Eligibility

Sex: ALLMin age: 6 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age 6-17 years and their parents * either 2 emergency department visits/prednisone bursts in the last 12 months or at least 1 asthma related hospitalization in the last 12 months * requiring daily controller therapy with either inhaled corticosteroids or combination corticosteroids/long acting beta agonist (LABA). * Patients using metered dose inhaler therapy would be eligible. Patients may also be on leukotriene antagonists, * Must be made aware that they will have to read and accept to the terms of the User Agreement prior to enrollment in the study. If they do not agree they will not be able to continue participation. The User agreement will be read agreed to electronically when they begin using the device, however a paper version will be provided at the time of consent upon request. Exclusion Criteria: * Primary language other than English or Spanish * Presence of other significant chronic lung disease including cystic fibrosis, interstitial lung disease, tracheostomy status. * Patients using diskus therapy. * Patients only on leukotriene antagonists.

Outcomes

Primary Outcomes

Number of patient participants that rate the devices as easy to use

Measuring the feasibility and acceptability of monitoring devices for children ages 6-17 who are at high risk for asthma exacerbation, by having children use the devices and having children/parents answer survey questions regarding their impressions of the product at the beginning of use and after 1.5 and 3 months of use.

Time frame: 3 months

Number of provider participants that rate the devices as easy to use

Measuring the feasibility and acceptability of monitoring devices for children ages 6-17 who are at high risk for asthma exacerbation, by having children use the devices and having providers answer survey questions regarding their impressions of the product at the beginning of use and after 1.5 and 3 months of use.

Time frame: 3 months

Secondary Outcomes

Number of patients/parents that exhibit behavioral changes with respect to taking asthma medications as a result of information gained from the monitoring devices.

How many parents/patients of high risk asthmatic children change behavior regarding how they administer their medications as a result of information that they gained from the devices regarding their adherence to their treatment regimen, gained via phone surveys at 1.5 and 3 months after using the devices. Patients are surveyed if children are greater than 12 years old. Parents are surveyed if children are 6-12 years old.

Time frame: 3 months

Number of pediatric pulmonary providers that exhibit behavioral changes with respect to prescribing asthma medications as a result of information gained from the monitoring devices.

Number of healthcare providers (physicians, nurse practitioners and physician assistants) that feel that their decision-making is affected regarding medication regimens for asthma based on information that they receive on patient adherence from the devices based on survey data gathered at study entry and 3 months after initiation of the devices will be measured.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.